Trevena Announces Closing of Public Offering and Partial Exercise of Underwriters’ Option to Purchase Additional Shares Dec 10, 2014 4:01 pm EST
Trevena Announces Positive Top-Line Results from Phase 2a/b Study of TRV130 in Acute Postoperative Pain Nov 17, 2014 4:01 pm EST
Trevena Reports Third Quarter 2014 Financial Results and Provides a Corporate Update Nov 11, 2014 7:00 am EST
Trevena Announces Early Completion of Enrollment of Phase 2a/b Study of TRV130 in Postoperative Pain Oct 8, 2014 7:00 am EDT